Literature DB >> 34357044

Inflammation in Metabolic and Cardiovascular Disorders-Role of Oxidative Stress.

Ying Sun1,2, Elias Rawish1,2,3, Henry M Nording1,2,3, Harald F Langer1,2,3.   

Abstract

Cardiovascular diseases (CVD) constitute the main cause of death worldwide. Both inflammation and oxidative stress have been reported to be involved in the progress of CVD. It is well known that generation of oxidative stress during the course of CVD is involved in tissue damage and inflammation, causing deleterious effects such as hypertension, dysfunctional metabolism, endothelial dysfunction, stroke, and myocardial infarction. Remarkably, natural antioxidant strategies have been increasingly discovered and are subject to current scientific investigations. Here, we addressed the activation of immune cells in the context of ROS production, as well as how their interaction with other cellular players and further (immune) mediators contribute to metabolic and cardiovascular disorders. We also highlight how a dysregulated complement system contributes to immune imbalance and tissue damage in the context of increases oxidative stress. Additionally, modulation of hypothalamic oxidative stress is discussed, which may offer novel treatment strategies for type-2 diabetes and obesity. Together, we provide new perspectives on therapy strategies for CVD caused by oxidative stress, with a focus on oxidative stress.

Entities:  

Keywords:  adipose tissue; cardiovascular diseases; hypothalamic dysfunction; metabolic disorders; oxidative stress

Year:  2021        PMID: 34357044     DOI: 10.3390/life11070672

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  8 in total

1.  Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS/caspase-1/GSDMD signaling pathway.

Authors:  Xiaoqing Zhang; Huiyan Qu; Tao Yang; Qian Liu; Hua Zhou
Journal:  Cell Cycle       Date:  2022-06-30       Impact factor: 5.173

2.  Adrenomedullin Improves Cardiac Remodeling and Function in Obese Rats with Hypertension.

Authors:  Pei Qian; Qian Wang; Fang-Zheng Wang; Hang-Bing Dai; Hong-Yu Wang; Qing Gao; Hong Zhou; Ye-Bo Zhou
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-06

3.  B-Cell Activating Factor Increases Related to Adiposity, Insulin Resistance, and Endothelial Dysfunction in Overweight and Obese Subjects.

Authors:  Diana Carolina Villalpando Sánchez; Sergio Gutiérrez Castellanos; Martha Eva Viveros Sandoval; Anel Gómez García
Journal:  Life (Basel)       Date:  2022-04-25

4.  The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of N-Methyl-d-aspartate Receptor Subunit 1 in Brain Cancer Cells for Alzheimer's Disease Application.

Authors:  Jung Sun Park; Taeyeon Kim; Dohoon Kim; Young-Il Jeong
Journal:  Int J Mol Sci       Date:  2021-11-15       Impact factor: 5.923

Review 5.  Platelets, Thromboinflammation and Neurovascular Disease.

Authors:  Ying Sun; Harald F Langer
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

6.  Higher Dietary Intake of Advanced Glycation End Products Is Associated with Faster Cognitive Decline in Community-Dwelling Older Adults.

Authors:  Michal Schnaider Beeri; Roni Lotan; Jaime Uribarri; Sue Leurgans; David A Bennett; Aron S Buchman
Journal:  Nutrients       Date:  2022-03-31       Impact factor: 6.706

Review 7.  Targeting Cell-Specific Molecular Mechanisms of Innate Immunity in Atherosclerosis.

Authors:  M Sauter; H F Langer
Journal:  Front Physiol       Date:  2022-04-01       Impact factor: 4.755

Review 8.  The Role of Mitochondrial DNA Mutations in Cardiovascular Diseases.

Authors:  Siarhei A Dabravolski; Victoria A Khotina; Vasily N Sukhorukov; Vladislav A Kalmykov; Liudmila M Mikhaleva; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.